Nurse-led group cognitive behavioral therapy had no effect on objective sleep measures but did improve patient-reported secondary outcomes<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Sept. 20, 2022 (HealthDay News) — For patients with rheumatoid arthritis (RA) and insomnia, nurse-led group-based cognitive behavioral therapy for insomnia (CBT-I) does not have an impact on sleep efficiency measured immediately after the intervention, but does improve patient-reported key secondary sleep and RA outcomes, according to a study published online Aug. 11 in Rheumatology<\/em>.<\/p>\n Kristine M. Latocha, Ph.D., from Copenhagen University Hospital-Rigshospitalet in Denmark, and colleagues conducted a randomized controlled trial to compare the effect of CBT-I with usual care on sleep efficiency, measured by polysomnography (PSG) at week seven, immediately after the intervention. The experimental intervention was six weeks of nurse-led group-based CBT-I, and the comparator was usual care. The intention-to-treat population comprised 62 patients (average sleep efficiency, 83.1 percent).<\/p>\n The researchers found that sleep efficiency as measured by PSG at week seven was 88.7 and 83.7 percent in the CBT-I and control groups, respectively. At week 26, there was no improvement in key secondary outcomes measured by PSG. However, statistically significant differences were seen between CBT-I and usual care for all patient-reported key secondary sleep- and RA-related outcomes at week 26, including insomnia and the RA impact of disease.<\/p>\n “CBT-I can potentially induce clinically meaningful effects on patient-reported outcomes — a finding that could have important clinical implications among patients with RA and insomnia,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n